J. Murphy, “Block a Protein, Starve a Tumor: Scientist reproduce a growth signal for capillaries,” Time Magazine, from Oct. 7, 1985, pp. 62. |
“Hemostasis and Blood Coagulation,” Blood Cells, Immunity, and Blood Clotting, pp. 99-110 (1995). |
Cope, Lewis, “Surgeon's treatment lets patients heal stubborn wounds with own blood,” Minneapolis Star and Tribune, Nov. 12, 1984. |
Antoniades et al., “Radioimmunoassy of a human serum growth factor for Balb/c-3T3 cells: Derivation from platelets,” Proc. Natl. Acad. Sci., vol. 74, pp. 1973-1977 (1997). |
Carpenter, “The Regulation of Cell Proliferation: Advances in the Biology and Mechanism of Action of Epidermal Growth Factor” J. Invest Dermatol., vol. 71, pp. 283-288 (1978). |
Deuel et al., “Platelet factor 4 is Chemotactic for Neutrophils and Monocytes,” Proc. Natl. Acad. Sci., vol. 78, pp. 4584-4587 (1981). |
“Evaluation of the efficacy and safety of Platelet Derived Wound Healing Formula (PDWHF, Homologous) in the treatment of chronic, nonhealing, cutaneous wounds: A multicenter, radomized, double-blind, placebo-controlled study: Protocol 202,” Prepared by CuraTech, Inc., Dec. 20, 1988. |
“Executive Summary: Platelet Derived Wound Healing Formula (PDWHF), Wound Care Center Program,” Prepared by Curatech, Inc. (1988). |
Frati et al., “Selective Binding of the Epidermal Growth Factor and Its Specific Effects on the Epithelial Cells of the Cornea,” Exper. Eye Res., vol. 14, pp. 135-141 (1972). |
Greaves, “Lack of Effect of Topically Applied Epidermal Growth Factor (EGF) on Epidermal Growth in Man in vivo,” Clinical and experimental Dermatology, vol. 5, pp. 101-103 (1980). |
Grotendorst “Can Collagen Metabolism Be Controlled?” J. Trauma. vol. 24, pp. 49-54, (1984). |
Grotendorst, G.R et al., “Platelet-Derived Growth Factor is a Chemoattractant for Vascular Smooth Muscle Cells”, Journal of Cellular Physiology, vol. 113, pp. 261-266 (1982). |
Grotendorst, G.R. et al., “Molecular Mediators of Tissue Repair” Surgical Science Series, vol. 2, pp. 20-40 (1984). |
Grotendorst, Gary R. et al., “Stimulation of Granulation Tissue formation by PDGF in Normal and Diabetic Rats,” (25 pages), manuscript (1985). |
Höckel, Michael, et al., “Purified Monocyte-derived Angiogenic Substance (Angiotropin) Induces Controlled Angiogenesis Associated with Regulated Tissue Proliferation in Rabbit Skin,” J. Clin. Invest., vol. 82, pp. 1075-1090 (1988). |
Hunt, T. “Can Repair Processes be Stimulated by Modulators (Cell Growth Factors, Angiogenic Factors, etc.) without Adversely effecting Normal Processes?” Frontiers in Understanding Burn Injury, 24(9) Supplement: S39-S46 (1984). |
Johnsson, A., et al., “Platelet-Derived Growth Factor: Identification of Constituent Polypeptides Chains” Biochemical and Biophysical Research Communications, vol. 104, No. 1, pp. 67-74 (1982). |
Knighton, D.R., et al., “Classification and Treatment of Chronic Nonhealing Wounds: Successful Treatment with Autologous Platelet-derived Wound Healing Factors (PDWHF)” Annals of Surgery, vol. 204 No. 3, pp. 322-330 (1986). |
Knighton, D.R., et al., “Role of Platelets and Fribrin in the Healing Sequence,” Annals of Surgery, vol. 196, No. 4, pp. 379-388 (1982). |
Knighton, D.R., et al., “The Use of Platelet Derived Wound Healing Formula In Human Clinical Trials,” pp. 1-12 (1987). |
Leitzel, et al., “Growth Factors and Wound Healing in the Hamster,” J. Dermetal. Surg. Oncl., vol. 11, No. 6, pp. 617-622 (1985). |
Linman, James MD, “Hemmorhagic Disorders” Hematology pp. 849-894 (1975). |
M.S. Banda et al., “Isolation of a nonmitogenic angiogenesis factor from wound fluid” Proc. Nat'l Acad. Sci. U.S.A., pp. 7773-7777 (1982). |
Michaeli, D., et al., “The Role of Platelets in Wound Healing: Demonstration of Angiogenic Activity,” Soft and Hard Tissue Repair, pp. 380-394 (1990). |
Niall et al., “The Effect of Epidermal Growth Factor on Wound Healing in Mice” J. Surg Res., vol. 33, 164-169 (1982). |
Sederma, Brochure: “Repair Factor F.C.P.” (41 pages), 1986. |
Robson, M. C., et al., “Platelet-derived growth factor BB for the treatment of chronic pressure ulcers,” The Lancet., vol. 339, pp. 23-25 (1992). |
Ross, R., and Vogel, A., “The Platelet-Derived Growth Factor,” (full citation not known) pp. 203-210 (1978). |
Senior, et al., “Chemotactic Activity of Platelet Granule Proteins for Fibroblasts” The Journal of Cell Biology, vol. 96, pp. 382-385 (1983). |
Sporn, M., et al., “Polypeptide Transforming Growth Factors Isolated from Bovine Sources and Used for Wound Healing in vivo,” Science., vol. 219, 1329-1331 (1983). |
Thorton et al., “Epidermal Growth Factor In the Healing of Second Degree Burns: a controlled Animal Study,” Burns, vol. 8, 156-160 (1981). |
Zetter, Bruce R. and Harry N. Antoniades, “Stimulation of Human Vascular Endothelial Cell Growth by a Platelet-Derived Growth Factor and Thrombin,” Journal of Supermolecular Structure, pp. 361-370 (1979). |